Recent Stories
American Biotech — The Future Can’t Be Won Without It.RSI is AI Building AI. What DC needs to know about it. Keeping the Human in Medicine: Two AI CoLab Researchers on What Machines Can’t ReplaceSomeone Is Hacking the Freezers. Pay Attention.Thinking of Running in 2028? Start HereWhat the Lame Duck Session Has to Do With the Ultimate 21st-Century Power Tool: Robots

The Wave

Senatein sessionHousein session
Refreshed just now
Money

NIH awarded Anivive Lifesciences Inc. contract 75N93024C00009 for biodefense vaccine candidate development under BAA Research Area 001.

Why it’s here: NIH award funding development of vaccine candidates for biodefense and emerging infectious diseases is a biotechnology program with federal biosecurity and pandemic preparedness relevance.

Trace across the board

Item

Connected

20 links

About

  • National Institutes of Health
  • Department of Health and Human Services

Analytics cookies help us see how the site is used. They only run if you accept. Privacy Policy

NIH awarded Anivive Lifesciences Inc. contract 75N93024C00009 for biodefense vaccine candidate development under BAA Research Area 001. — The Wave